Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Partridge

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2006
Non-adherence to endocrine therapy for breast cancerA H Partridge
Cancer Treatment and Research|July 14, 2009
FertilityK J Ruddy, A H Partridge
Seminars in Oncology|December 29, 2000
Long-term outcomes of children exposed to antineoplastic agents in uteroA H Partridge, J E Garber
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2009
Adherence with adjuvant hormonal therapy for breast cancerK J Ruddy, A H Partridge
Breast Disease|February 3, 2005
Quality of life issues among women undergoing high-dose chemotherapy for breast cancerA H Partridge, C A Bunnell, E P Winer
Journal of the National Cancer Institute. Monographs|January 5, 2002
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancerA H Partridge, H J Burstein, E P Winer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Menopausal-type symptoms in young breast cancer survivorsM G Leining, S Gelber, R Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009
Genetic testing in young women with breast cancer: results from a Web-based surveyK J Ruddy, S Gelber, J Shin, et al.
Breast Cancer Research and Treatment|March 19, 2009
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerE L Mayer, A H Partridge, L N Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factorD P Schenkein, Y Koc, T Alcindor, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2006
Non-adherence to endocrine therapy for breast cancerA H Partridge
Cancer Treatment and Research|July 14, 2009
FertilityK J Ruddy, A H Partridge
Seminars in Oncology|December 29, 2000
Long-term outcomes of children exposed to antineoplastic agents in uteroA H Partridge, J E Garber
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2009
Adherence with adjuvant hormonal therapy for breast cancerK J Ruddy, A H Partridge
Breast Disease|February 3, 2005
Quality of life issues among women undergoing high-dose chemotherapy for breast cancerA H Partridge, C A Bunnell, E P Winer
Journal of the National Cancer Institute. Monographs|January 5, 2002
Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancerA H Partridge, H J Burstein, E P Winer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Menopausal-type symptoms in young breast cancer survivorsM G Leining, S Gelber, R Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009
Genetic testing in young women with breast cancer: results from a Web-based surveyK J Ruddy, S Gelber, J Shin, et al.
Breast Cancer Research and Treatment|March 19, 2009
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerE L Mayer, A H Partridge, L N Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factorD P Schenkein, Y Koc, T Alcindor, et al.
Pageof 4